DE60127917D1 - Verwendung von gamma-CEHC als Antioxidantien - Google Patents

Verwendung von gamma-CEHC als Antioxidantien

Info

Publication number
DE60127917D1
DE60127917D1 DE60127917T DE60127917T DE60127917D1 DE 60127917 D1 DE60127917 D1 DE 60127917D1 DE 60127917 T DE60127917 T DE 60127917T DE 60127917 T DE60127917 T DE 60127917T DE 60127917 D1 DE60127917 D1 DE 60127917D1
Authority
DE
Germany
Prior art keywords
cehc
antioxidants
gamma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60127917T
Other languages
English (en)
Other versions
DE60127917T2 (de
Inventor
Kazuo Kondo
Osamu Igarashi
Chikako Kiyose
Hiroyuki Yoshimura
Shigehiro Yoshitake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai R&D Management Co Ltd
Original Assignee
Eisai R&D Management Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Management Co Ltd filed Critical Eisai R&D Management Co Ltd
Publication of DE60127917D1 publication Critical patent/DE60127917D1/de
Application granted granted Critical
Publication of DE60127917T2 publication Critical patent/DE60127917T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DE60127917T 2000-09-27 2001-09-18 Verwendung von gamma-CEHC als Antioxidantien Expired - Lifetime DE60127917T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000294802 2000-09-27
JP2000294802 2000-09-27

Publications (2)

Publication Number Publication Date
DE60127917D1 true DE60127917D1 (de) 2007-05-31
DE60127917T2 DE60127917T2 (de) 2007-12-20

Family

ID=18777329

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60127917T Expired - Lifetime DE60127917T2 (de) 2000-09-27 2001-09-18 Verwendung von gamma-CEHC als Antioxidantien

Country Status (4)

Country Link
US (1) US6780886B2 (de)
EP (1) EP1199075B1 (de)
DE (1) DE60127917T2 (de)
ES (1) ES2284573T3 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048891A (en) * 1998-12-17 2000-04-11 Loma Linda University Medical Center Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of natriuretic disease
US7119117B2 (en) * 2001-08-21 2006-10-10 Galileo Pharmaceuticals, Inc. Tocopherol enriched compositions and amelioration of inflammatory symptoms
US20030144219A1 (en) * 2001-11-15 2003-07-31 Phinney Stephen Dodge Formulations and methods for treatment or amelioration of inflammatory conditions
CA2545788A1 (en) * 2003-11-13 2005-06-02 Galileo Pharmaceuticals, Inc. Plant-derived protein extract compositions and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0543417A1 (de) * 1991-11-22 1993-05-26 Lipogenics, Incorporated Tocotrienole und Focotrienol-ähnliche Verbindungen und Verfahren zu ihrer Verwendung
FR2727414A1 (fr) * 1994-11-25 1996-05-31 Pf Medicament Derives de 3,4-dihydro-2,5,7,8-tetramethyl-benzopyran-6-ol, utiles comme medicaments
US6048891A (en) * 1998-12-17 2000-04-11 Loma Linda University Medical Center Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of natriuretic disease

Also Published As

Publication number Publication date
EP1199075A3 (de) 2002-10-30
EP1199075B1 (de) 2007-04-18
US6780886B2 (en) 2004-08-24
DE60127917T2 (de) 2007-12-20
US20020040053A1 (en) 2002-04-04
EP1199075A2 (de) 2002-04-24
ES2284573T3 (es) 2007-11-16

Similar Documents

Publication Publication Date Title
DE60044004D1 (de) Verwendung von Omega-Carboxyaryl-substituierten Diphenylharnstoffen als raf-Kinase-Inhibitoren
DE60134094D1 (de) C7-taxanester als antitumormittel
DE60143301D1 (de) Polyarylcarboxamide zur verwendung als lipidsenker
ATE297907T1 (de) Alpha-acyl- und alpha-heteroatom-substituierte benzenacetamide verwendbar als glucokinase- aktivatoren
ATE280163T1 (de) Substituierte phenylacetamide und ihre verwendung als glukokinase aktivatoren
DE60227932D1 (de) Spannungsregler
DE60106022D1 (de) Thiophenverbindungen zur verwendung als antikrebsmittel
DE50212455D1 (de) Verwendung von Dimerdiolen
ATE333794T1 (de) Verwendung herbizider mittel
DE50012379D1 (de) Verwendung von nanoskaligen antischuppenwirkstoffen
DE60127311D1 (de) Verbesserung von luftbleichkatalysatoren
DE502004011575D1 (de) Verwendung von Dioldimerfettsäureestern
DE50104706D1 (de) Verwendung von benzophenanthridinalkaloiden als futterzusatzmittel
DE50206096D1 (de) Substituierte benzoäbüazepin-2-on-verbindungen als schmerzmittel
DE60007360T2 (de) Amorphe modifikation von torasemid
DE60127917D1 (de) Verwendung von gamma-CEHC als Antioxidantien
DE60107055D1 (de) Thienopyridinderivate zur verwendung als entzündungshemmende mittel
DE50106738D1 (de) Schaltwandler
DE69931182D1 (de) Verwendung von triclosan als antimalariamittel
ATE348606T1 (de) Neue verwendung von pipatalin
DE60227549D1 (de) Verwendung von leptin bei unfruchtbarkeit
DE50101155D1 (de) Gerbstoff-/Nachgerbstoffpräparationen
DE60207463D1 (de) Verwendung von Pyranen als Riechstoffe
ATE282039T1 (de) Pyrazolopyridinon als zwischenprodukt
DE60233601D1 (de) Verwendung von bestimmten Cyclolignanen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition